Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

The G-CSF Produces Long-Term Changes in Gene and Mirnas Expression Profiles in CD34+ From Healthy Donors

Alicia Báez, Concepción Prats-Martín, M.D, Isabel Álvarez-Laderas, Estefania Garcia, Luis Ignacio Sanchez-Abarca, Ph.D., Beatriz Martin-Antonio, Ph.D., Alvaro Urbano-Ispizua, MD, Jose Antonio Pérez Simón, MD, PhD

Blood (2012) 120 (21): 588.

https://doi.org/10.1182/blood.V120.21.588.588

Published: 2012

Journal Articles

Patterns of Infection in Patients with Myeloid Malignancies Receiving 5-Azacytidine: identification of Candidates for Antifungal Prophylaxis

Cristina Calderón, MD, Jose F Falantes, MD, Francisco Márquez-Malaver, MD, Jose González, MD, PhD, Maria Luz Martino, MD, Isabel Montero, MD, Ildefonso Espigado, MD, PhD, Jose Antonio Pérez-Simón, MD, PhD

Blood (2012) 120 (21): 4955.

https://doi.org/10.1182/blood.V120.21.4955.4955

Published: 2012

Journal Articles

Mirnas and Gene Expression Profiles in CD34+ Cells Are Dependent On the Source of Progenitor Cells Employed in Transplantation.

Alicia Báez, Beatriz Martin-Antonio, Ph.D., Concepción Prats-Martín, M.D, Isabel Álvarez-Laderas, María Victoria Barbado, Ph.D, Teresa Caballero-Velázquez, Jose Ignacio Piruat, Ph.D, Magdalena Carmona, MD, Jose Antonio Pérez-Simón, Sr., MD, PhD, Alvaro Urbano-Ispizua, MD/Ph.D

Blood (2012) 120 (21): 3020.

https://doi.org/10.1182/blood.V120.21.3020.3020

Published: 2012

Journal Articles

Rituximab, Either As Single Agent or in Combination, Is Superior to Other Treatments in Terms of Response Rate and Progression-Free Survival (PFS) in Patients with Splenic Marginal Zone Lymphoma (SMZL)

Ana Marin-Niebla, MD, Monica Else, MA, MSc, Fatima De la Cruz, MD, Paul Batty, MD, Eduardo Rios-Herranz, MD, Claire E. Dearden, Ildefonso Espigado, MD, PhD, Jose Antonio Pérez Simón, MD, PhD, Daniel Catovsky, MD, Estella Matutes

Blood (2011) 118 (21): 4986.

https://doi.org/10.1182/blood.V118.21.4986.4986

Published: 2011

Journal Articles

Prognostic Factors for Survival and Progression to Acute Myeloid Leukemia in Patients with Lower-Risk Myelodysplastic Syndromes. A New Scoring System

Jose F Falantes, MD, Cristina Calderón, MD, Ildefonso Espigado, MD, PhD, Dora Alonso, MD, Antonio Martín Noya, MD, PhD, Estrella Carrillo, MD, Maria Luz Martino, MD, Isabel Montero, MD, Jose González, MD, PhD, Jose Antonio Pérez-Simón, MD, PhD

Blood (2011) 118 (21): 1730.

https://doi.org/10.1182/blood.V118.21.1730.1730

Published: 2011

Journal Articles

Multiparameter Flow Cytometry Analysis of Peripheral Blood T, NK and Dendritic Cells From High-Risk Smoldering Multiple Myeloma Patients Treated with Lenalidomide and Dexamethasone

Bruno Paiva, Lucía López-Corral, María-Belén Vidriales, Luis Ignacio Sánchez Abarca, Miguel T. Hernandez, Joan Bargay, Javier De La Rubia, Pilar Giraldo, Ana-Isabel Teruel, Laura Rosiñol, Albert Oriol, Jose Hernández, Felipe de Arriba, Graça Esteves, Jose Antonio Pérez Simón, María-Victoria Mateos, Jesus F San Miguel

Blood (2010) 116 (21): 1906.

https://doi.org/10.1182/blood.V116.21.1906.1906

Published: 2010

Journal Articles

Effect of 5-Azacytidine (5-AzaC) In the Expression of PRAME In Acute Myeloid Leukemia (AML)

Silvia Gutiérrez Cosío, Esteban Ballestar, Carlos Santamaría, Belen Blanco, Luis Ignacio Sánchez Abarca, Teresa Caballero Velázquez, Carmen Herrero Sánchez, Soraya Carrancio, Laura Ciudad, Consuelo Cañizo, Jesus F San Miguel, Jose Antonio Pérez Simón

Blood (2010) 116 (21): 3615.

https://doi.org/10.1182/blood.V116.21.3615.3615

Published: 2010

Journal Articles

Effect of Demethylating Agents (5-Azacytidine/5-AzaC) On the Immune Response

Silvia Gutiérrez Cosío, Esteban Ballestar, Carlos Santamaría, Belén Blanco, Luis Ignacio Sánchez Abarca, Teresa Caballero Velázquez, Carmen Herrero Sánchez, Soraya Carrancio, Laura Ciudad, Consuelo Cañizo, Jesus F San Miguel, Jose Antonio Pérez Simón

Blood (2010) 116 (21): 2771.

https://doi.org/10.1182/blood.V116.21.2771.2771

Published: 2010

Journal Articles

Association Between the Hematopoietic Cell Transplantation-Specific Comorbidity Index (CI) and Non-Relapse Mortality (NRM) After Reduced Intensity Conditioning (RIC) Allogeneic Stem Cell Transplantation (allo-SCT) for Acute Myeloid Leukemia (AML) in First Complete Remission (CR1).

Mohamad Mohty, MD, PhD, Myriam Labopin, Nadezda Basara, Jan J. Cornelissen, MD, PhD, Reza Tabrizi, Claes Malm, M.D., Jose Antonio Pérez Simón, Arnon Nagler, Nicolaus Kroger, Bernard Rio, Rodrigo Martino, MD, Matthias Eder, MD, Karin Bilger, MD, Donald W. Bunjes, MD, PhD, Gérard Socié, MD, Didier Blaise, MD, Emmanuelle Polge, Vanderson Rocha, MDPhD

Blood (2009) 114 (22): 650.

https://doi.org/10.1182/blood.V114.22.650.650

Published: 2009

Journal Articles

Both Expanded and Uncultured Mesenchymal Stem Cells from MDS Patients Are Genomically Abnormal, Showing a Specific Genetic Profile for the 5q- Syndrome.

Olga López Villar, MD, Juan LuíS. García, PhD, Fermín. M Sánchez Guijo, MD, PhD, Cristina Robledo, Pilar Hernandez Campo, PhD, Maria Diez Campelo, MD, PhD, Sandra Muntion, Jose Antonio Pérez Simón, MD, PhD, J.F. San Miguel, MD, PhD, MaríA. Consuelo Del Cañizo, MD, PhD

Blood (2008) 112 (11): 1650.

https://doi.org/10.1182/blood.V112.11.1650.1650

Published: 2008

Journal Articles

Mesenchymal Stem Cells from Patients with Myelodysplastic Syndromes Are Functionally and Genomically Abnormal.

Olga López Villar, MD, Fermin M. Sánchez-Guijo, PhD, Juan Luis García, PhD, Jose Ramon González Porras, PhD, Eva Villarón, PhD, Natalia López-Holgado, PhD, Jose Antonio Pérez Simón, PhD, J.F. San Miguel, PhD, María Consuelo Del Cañizo, PhD

Blood (2007) 110 (11): 1916.

https://doi.org/10.1182/blood.V110.11.1916.1916

Published: 2007

NARROW

The G-CSF Produces Long-Term Changes in Gene and Mirnas Expression Profiles in CD34+ From Healthy Donors

Patterns of Infection in Patients with Myeloid Malignancies Receiving 5-Azacytidine: identification of Candidates for Antifungal Prophylaxis

Mirnas and Gene Expression Profiles in CD34+ Cells Are Dependent On the Source of Progenitor Cells Employed in Transplantation.

Rituximab, Either As Single Agent or in Combination, Is Superior to Other Treatments in Terms of Response Rate and Progression-Free Survival (PFS) in Patients with Splenic Marginal Zone Lymphoma (SMZL)

Prognostic Factors for Survival and Progression to Acute Myeloid Leukemia in Patients with Lower-Risk Myelodysplastic Syndromes. A New Scoring System

Multiparameter Flow Cytometry Analysis of Peripheral Blood T, NK and Dendritic Cells From High-Risk Smoldering Multiple Myeloma Patients Treated with Lenalidomide and Dexamethasone

Effect of 5-Azacytidine (5-AzaC) In the Expression of PRAME In Acute Myeloid Leukemia (AML)

Effect of Demethylating Agents (5-Azacytidine/5-AzaC) On the Immune Response

Association Between the Hematopoietic Cell Transplantation-Specific Comorbidity Index (CI) and Non-Relapse Mortality (NRM) After Reduced Intensity Conditioning (RIC) Allogeneic Stem Cell Transplantation (allo-SCT) for Acute Myeloid Leukemia (AML) in First Complete Remission (CR1).

Both Expanded and Uncultured Mesenchymal Stem Cells from MDS Patients Are Genomically Abnormal, Showing a Specific Genetic Profile for the 5q- Syndrome.

Mesenchymal Stem Cells from Patients with Myelodysplastic Syndromes Are Functionally and Genomically Abnormal.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only